| Literature DB >> 29922701 |
Sudip Bhattacharya1, Amarjeet Singh1.
Abstract
Childhood blindness due to corneal ulceration was prevalent among poor Indian children. To tackle this situation, the National Institute of Nutrition (NIN), Hyderabad, India, Vitamin-A (Vit-A) prophylaxis programme was launched nationally in 1970 after field testing. Research of Indian Council for Medical Research (ICMR) documented that prevalence of Vit-A deficiency signs such as Bitot's spot decreased among children, over a period of time. However, this decrease cannot be ascertained is due to mass Vit-A prophylaxis programme. This is because coverage was low and patchy. Improved nutrition status, wider vaccination coverage, increased rate in breast feeding and improvement of healthcare services played a crucial role. Rather many studies revealed that (mass prophylaxis to the child who is having adequate Vit-A level) it may be harmful to certain group of children as a result of acute toxic symptoms. High dose of Vit-A is capable of loss of bone density-hence retarded growth may be observed in susceptible individuals. To tackle this issue food based approach should be promoted (which includes breast feeding) along with timely measles vaccination. The children who have signs of Vit-A deficiency (e.g. night blindness, xeropthalmia, Bitot's spot) or post measles children should receive Vit-A in age specific daily doses for two weeks along with Vit-A rich food, like green leafy vegetables, red palm oil, liver etc. Public spirited citizens, together with scientific community in India, should discourage this "one size fit to all" approach. It will not only avoid the ill effects of high dose of Vit-A but also it will help us optimal utilization of health resources in a resource poor country like India.Entities:
Keywords: Vitamin-A toxicity; keratomalacia; mortality
Year: 2017 PMID: 29922701 PMCID: PMC5963117 DOI: 10.3934/publichealth.2017.1.38
Source DB: PubMed Journal: AIMS Public Health ISSN: 2327-8994
Summary of Studies recommended for phasing out of mega dose of Vit-A supplementation.
| Published article/commentary | Conclusions |
Latham M. The great vitamin A fiasco. | Megadose of Vitamin-A shall be scrapped |
Gopalan, Sachdev, Kapil, Soekirman et al. Responses to The great vitamin A fiasco. World Nutrition June 2010; 1, 2: 78–119. | Mega dose do harm, Food-based approaches are best |
Gopalan, Sachdev, Kapil, Soekirman et al. Responses to The great vitamin A fiasco. World Nutrition June 2010; 1, 2: 78–119. | Time to phase out the universal Vitamin-A supplementation programme |
Gopalan, Sachdev, Kapil, Soekirman et al. Responses to The great vitamin A fiasco. World Nutrition June 2010; 1, 2: 78–119. | Vitamin-A capsules have been the major focus of the Vitamin-A deficiency eradication programme in Indonesia. But other programmes, such as fortification, are crucial. Public health interventions in general still face a lot of challenges in Indonesia. Slowly we are addressing many of the underlying factors that affect Vitamin-A status, such as breastfeeding, home gardens, water supply, sanitation, immunisation, and health education |
Nesheim M. Need for long-term benefits. [Letter] World Nutrition, June 2010, 1, 2: 106. | Support for local agriculture, and for health and sanitation initiatives, are likely to provide the long-term health benefits |
Reddy V. Need for food-based programmes. [Letter] World Nutrition, June 2010, 1, 2: 106–107. | Vitamin-A may have the potential to avert deaths in children, as shown in some of the controlled trials with adequate coverage. But the mortality impact has not been demonstrated in populations where the Vitamin-A programme has been in operation for several years, since the children who are at greatest risk are often inaccessible. The wisdom and validity of the current practice of giving large doses of Vitamin-A to young children has also been questioned |
Lyons G. Need to go and stay local. [Letter] World Nutrition, June 2010, 1, 2: 112–113. | In the 1970s there was a measles outbreak in North Malaita where children were going blind not just because of Vitamin-A deficiency, but because of the combination of deficiency and measles. |
Amdekar Y A et al. Vitamin Controversy. World Nutrition, June 2010, 1, 2: 114–116. | In summary, routine supplements of vitamins are unnecessary. It may be required for normal pre-term new-borns. Otherwise supplements of vitamins should be reserved for treatment of deficiency states. Those who need vitamin supplements often require therapeutic doses of vitamins to treat specific deficiencies, and are not benefited by routine doses |
Summary of Studies Linking Vit-A with Reduction of Mortality and Morbidity.
| Study and area | Sample | Intervention (Vitamin A) | Outcome measures | Overall Reduction | |||
| age (mo) | size | adequacy | mortality | morbidity | |||
| Rahamathullah et al. | 6–60 | 15419 | Not mentioned | 8333 IU per week | mortality(include accidental deaths) morbidity (ARI, diarrhea); long recall period | yes | no |
| Vijayraghavan et al. | 12–60 | 15775 | Not mentioned | 2,00,000 IU 6 monthly, 2 doses | mortality (cause not ascertained), morbidity (ARI, diarrhea); severity not assessed | no | no |
| Kothari | <12 | 387 | Not mentioned | 2,00,000 IU, doses? duration? frequency? | mortality (cause not ascertained), morbidity (not defined) follow up over 3 years | yes | no |
| Ramakrishnan et al. | 6–36 | 583 | adequate to detect 25% reduction in morbidity | 1,00,000 IU to <1 yr, 2,00,000 IU to > 1yr, 4 monthly for 1 yr | morbidity (ARI, diarrhea) defined and assessed for frequency and duration | - | no |
| Agarwal et al. | 1–72 | 15247 And 2514 | not mentioned | 50,000 IU to <6 mo, 1,00,000 IU to >6 mo, 4 monthly for 1 yr | mortality (cause ascertained), morbidity (measles, ARI, Otitis media, skin infections) | yes? | yes |
| Bhandari et al. | 12–60 | 900 | adequate to detect 25% reduction in diarrhea | 2,00,000 IU single dose | morbidity (ARI, diarrhea) defined and assessed for 3 months after acute diarrheal episode | - | no |
| Dewan et al. | 6–60 | 216 | not mentioned | 1,00,000 IU single dose | duration of acute diarrheal episode, no long term follow-up. | - | no |
| Venkatarao et al. | Newly born and her mother | 909 pairs | adequate to detect 10% reduction in ARI/diarrhea incidence | 3,00,000 IU to mother and 2,00,000 IU to infant at 6 mo of age | morbidity (ARI, diarrhea) defined and assessed for incidence, severity and duration, till 1 yr of age | - | no |
| Coles et al. | 0–6 | 465 | power to detect differences was low | 7000 µg retinol, 2 doses within 48 h of birth | Nasopharyngeal pneumococcal carriage at 2,4,6 mo of age, mortality, morbidity not analyzed | - | - |